Rare diseases
Investigational molecules
Locations
Thurgauerstrasse 54, 8050
Clinical research includes moderate to severe active ulcerative colitis, with interest in biologic treatment pathways and biosimilar development for immune-mediated intestinal inflammation.
The sponsor’s work in this area is centred on therapeutic options for chronic gastrointestinal inflammation and related immune disease management.
Alvotech Swiss AG runs clinical trials in conditions such as Diabetic retinal oedema, Malignant melanoma stage III, Acute haemorrhagic ulcerative colitis, Diabetic retinopathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Romania
BulgariaBulgaria
LatviaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
